|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-6-17
|
|
pubmed:abstractText |
The prognostic value of tumour proliferation and apoptosis measurements were studied prospectively in patients with carcinoma of the uterine cervix, relative to other established clinical factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-101
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10225562-Analysis of Variance,
pubmed-meshheading:10225562-Antimetabolites,
pubmed-meshheading:10225562-Apoptosis,
pubmed-meshheading:10225562-Bromodeoxyuridine,
pubmed-meshheading:10225562-Carcinoma,
pubmed-meshheading:10225562-Cell Division,
pubmed-meshheading:10225562-Disease-Free Survival,
pubmed-meshheading:10225562-Female,
pubmed-meshheading:10225562-Flow Cytometry,
pubmed-meshheading:10225562-Follow-Up Studies,
pubmed-meshheading:10225562-Hemoglobins,
pubmed-meshheading:10225562-Humans,
pubmed-meshheading:10225562-Immunohistochemistry,
pubmed-meshheading:10225562-Middle Aged,
pubmed-meshheading:10225562-Mitosis,
pubmed-meshheading:10225562-Multivariate Analysis,
pubmed-meshheading:10225562-Neoplasm Recurrence, Local,
pubmed-meshheading:10225562-Neoplasm Staging,
pubmed-meshheading:10225562-Ploidies,
pubmed-meshheading:10225562-Prognosis,
pubmed-meshheading:10225562-Proportional Hazards Models,
pubmed-meshheading:10225562-Prospective Studies,
pubmed-meshheading:10225562-Remission Induction,
pubmed-meshheading:10225562-S Phase,
pubmed-meshheading:10225562-Survival Rate,
pubmed-meshheading:10225562-Time Factors,
pubmed-meshheading:10225562-Treatment Outcome,
pubmed-meshheading:10225562-Uterine Cervical Neoplasms
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
